McIlrath & Eck’s Fabrinet FN Stock Holding History

McIlrath & Eck’s Portfolio FN Stock Details FN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-338	Closed	-$27K	–	856
2022 Q2	$27K	Sell	338 -83	-20%	-$7.46K	0.01%	336
2022 Q1	$44K	Sell	421 -61	-13%	-$6.44K	0.01%	261
2021 Q4	$57K	Hold	482	–	–	0.02%	226
2021 Q3	$49K	Buy	482 +120	+33%	+$11.8K	0.01%	236
2021 Q2	$35K	Hold	362	–	–	0.01%	283
2021 Q1	$33K	Buy	+362	New	+$31.4K	0.01%	253

Other funds holding FN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

McIlrath & Eck's FN Position: Q3 2022 in Review

McIlrath & Eck sold out of Fabrinet (FN) in Q3 2022, closing a stake of 338 shares — an estimated $27K sold.

McIlrath & Eck first reported a position in FN in Q1 2021 and held it in 6 quarters. The position peaked at $57K in Q4 2021. 255 funds tracked by Wall St. Rank hold FN as of Q3 2022.

McIlrath & Eck reported no remaining Fabrinet position as of Q3 2022 after selling out during the quarter.
McIlrath & Eck sold 338 Fabrinet shares in Q3 2022, an estimated $27K.
McIlrath & Eck first reported a position in Fabrinet in Q1 2021 and held it in 6 quarters.
McIlrath & Eck's Fabrinet position peaked at $57K in Q4 2021.
255 funds tracked by Wall St. Rank held Fabrinet as of Q3 2022.

Based on McIlrath & Eck's 13F filing for Q3 2022, filed 18 Oct 2022.